Skip to main content
. 2014 May 8;2014:364819. doi: 10.1155/2014/364819

Figure 4.

Figure 4

MD trajectories for (a) protein-ligand complex RMSD, (b) ligand RMSD, and (c) total energy. Trajectories for Tacrolimus, Daphnetoxin, 20-O-(2′E,4′E-decadienoyl)ingenol, and Lythrancine II are shown in pink, mint, blue, and violet, respectively.